Abstract: Disclosed herein are various embodiments, for a fast boot system. An example embodiment operates by determining that one or more programs have been loaded into memory on a boot-up of a device. A snapshot of the memory including the loaded one or more programs is captured. Operations of the device are monitored after the snapshot has been captured. It is determined that a first program of the one or more programs was updated during the monitoring. A restart of the device is detected, wherein the snapshot is loaded into the memory in lieu of loading the one or more programs, and wherein the first program is updated during the restart of the device.

Abstract: The present invention is related to coating compositions, in particular for seeds of leguminous crops. The present disclosure provides a liquid composition for seed coating comprising from 10 to 250 g/l of molybdenum, 0.001 to 1.0 weight % of a vitamin B12, and 0.1 to 10 weight % of a compound selected from the group consisting of succinic acid, malic acid, maleic acid, tartaric acid, fumaric acid, any salts thereof, and any mixtures thereof. The present disclosure also provides a method for preparing seeds of leguminous crops, and the use of a liquid composition for the coating of seeds of leguminous crops or for soil application.

Abstract: This invention relates to compounds useful as lysyl oxidase (LOX) and lysyl oxidase-like (LOXL) family member (LOXL1, LOXL2, LOXL3, LOXL4) inhibitors. In addition there are contemplated pharmaceutical compositions comprising the compounds and the use of the compounds in the treatment of conditions mediated by LOX and LOXL, for example cancer. In particular a LOX inhibitor such as the present compounds may be for use in the treatment of a cancer associated with EGFR. The present invention also contemplates the identification of biomarkers that predict responsiveness to a LOX inhibitor.

Abstract: Disclosed herein are various embodiments, for a fast boot system. An example embodiment operates by determining that one or more programs have been loaded into memory on a boot-up of a device. A snapshot of the memory including the loaded one or more programs is captured. Operations of the device are monitored after the snapshot has been captured. It is determined that a first program of the one or more programs was updated during the monitoring. A restart of the device is detected, wherein the snapshot is loaded into the memory in lieu of loading the one or more programs, and wherein the first program is updated during the restart of the device.

Abstract: An aqueous composition including phosphorus, from 2.0 to 20 weight % of boron, and from 2.0 to 20 weight % of a seaweed extract, a method for producing the aqueous composition, and the use of the aqueous composition as a fertilizer.

Abstract: Inhibition of quorum sensing in Gram-negative bacteria, particularly strains of Vibrio, by certain compounds is disclosed. Compositions to treat bacterial infections and methods to treat such infections are also provided.

Abstract: Systems and methods for reducing data loss in remote databases. One method includes detecting, with an electronic processor communicatively coupled to the remote database, a failure of a user session with the remote database. The method includes, in response to determining the failure of the user session, performing, with the electronic processor, an offline detection check for the user session, the offline detection check including a canary check on a known resource related to the remote database. The method includes, in response to the offline detection check indicating that the remote database is offline, setting the user session to read-only, displaying, within a graphical user interface of the user session, an offline indicator, and graphically marking the at least one outstanding request within the user session.

Abstract: Systems and methods for reducing data loss in remote databases. One method includes detecting, with an electronic processor communicatively coupled to the remote database, a failure of a user session with the remote database. The method includes, in response to determining the failure of the user session, performing, with the electronic processor, an offline detection check for the user session, the offline detection check including a canary check on a known resource related to the remote database. The method includes, in response to the offline detection check indicating that the remote database is offline, setting the user session to read-only, displaying, within a graphical user interface of the user session, an offline indicator, and graphically marking the at least one outstanding request within the user session.

Abstract: Systems and methods for reducing data loss in remote databases. One method includes detecting, with an electronic processor communicatively coupled to the remote database, a failure of a user session with the remote database. The method includes, in response to determining the failure of the user session, performing, with the electronic processor, an offline detection check for the user session, the offline detection check including a canary check on a known resource related to the remote database. The method includes, in response to the offline detection check indicating that the remote database is offline, setting the user session to read-only, displaying, within a graphical user interface of the user session, an offline indicator, and graphically marking the at least one outstanding request within the user session.

Abstract: The present invention relates to novel human antibodies specifically directed against human immunoglobulin E (anti-IgE). The present invention also relates to pharmaceutical compositions and methods for treating asthma, in particular allergic asthma, as well as other IgE-mediated disorders including allergic rhinitis and food allergies.

Abstract: The present invention relates to novel human antibodies specifically directed against human immunoglobulin E (anti-IgE). The present invention also relates to pharmaceutical compositions and methods for treating asthma, in particular allergic asthma, as well as other IgE-mediated disorders including allergic rhinitis and food allergies.

Abstract: The present invention relates to novel human antibodies specifically directed against human immunoglobulin E (anti-IgE). The present invention also relates to pharmaceutical compositions and methods for treating asthma, in particular allergic asthma, as well as other IgE-mediated disorders including allergic rhinitis and food allergies.